Human endogenous retroviruses (HERVs) are ancestral viral relics that constitute nearly 8%
of the human genome. Although normally silenced, the most recently integrated provirus …

Simple Summary A rapidly emerging new approach to treat cancer involves collection of
patient immune white blood cells and genetic re-programming of the cells to express a new …

Cellular fusion eg between cancer cells and normal cells represents a stepwise process that
is tightly regulated. During a pre-hybrid preparation program somatic cells and/or cancer …

Human endogenous retroviruses (HERVs) comprise nearly 8% of the human genome and
are derived from ancient integrations of retroviruses into the germline. The biology of HERVs …

Human endogenous retroviruses (HERVs) comprise about 8.3% of the human genome and
are capable of producing RNA molecules that can be sensed by pattern recognition …

The most active human endogenous retrovirus K (HERV-K) subtype, HML-2, has been
implicated as a driver of oncogenesis in several cancers. However, the presence and …

Human endogenous retrovirus-K (HERV-K) is the most recently integrated retrovirus in the
human genome, with implications for multiple disorders, including cancer. Although typically …

Approximately 8% of the human genome, over four times more than its protein-coding
regions, comprises sequences of viral origin that are known as human endogenous …

The human endogenous retrovirus K (HERV-K) is the most recently acquired endogenous
retrovirus in the human genome and is activated and expressed in many cancers and …

In this article we review complications to the peripheral nervous system that occur as a
consequence of viral infections, with a special focus on complications of severe acute …